Lead Product(s): Antibodies
Therapeutic Area: Immunology
Highest Development Status: Discovery Product Type: Large molecule
Partner/Sponsor/Collaborator: Inotrem S.A
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration May 07, 2020
As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.